Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis.
about
Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteineBlocking the 4-1BB Pathway Ameliorates Crystalline Silica-induced Lung Inflammation and Fibrosis in MiceLevels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments.Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium.Anthracycline induced cardiotoxicity: biomarkers and "Omics" technology in the era of patient specific care.New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.Circulating Fibrocytes Are Increased in Neonates with Bronchopulmonary Dysplasia.Role of Circulating Fibrocytes in Cardiac FibrosisUpregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosisThe antifibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosis.An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis.Immune Mechanisms in Pulmonary Fibrosis.Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.Is pirfenidone ready for use in non-idiopathic pulmonary fibrosis interstitial lung diseases?Pirfenidone ameliorates concanavalin A-induced hepatitis in mice via modulation of reactive oxygen species/nuclear factor kappa B signalling pathways.Therapeutic effects of telomerase in mice with pulmonary fibrosis induced by damage to the lungs and short telomeres.Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis.Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.Effect of grapefruit juice and food on the pharmacokinetics of pirfenidone in healthy Chinese volunteers: a diet-drug interaction study.Pirfenidone exerts a suppressive effect on CCL18 expression in U937-derived macrophages partly by inhibiting STAT6 phosphorylation.Pyrrolidine dithiocarbamate attenuates paraquat-induced acute pulmonary poisoning in vivo via transforming growth factor β1 and nuclear factor κB pathway interaction.A fully automated image analysis method to quantify lung fibrosis in the bleomycin-induced rat model.The diversity of myeloid immune cells shaping wound repair and fibrosis in the lung.Macrophages: friend or foe in idiopathic pulmonary fibrosis?Development of an Improved Inhalable Powder Formulation of Pirfenidone by Spray-Drying: In Vitro Characterization and Pharmacokinetic Profiling
P2860
Q26777928-14752406-6B45-4E3E-90C1-500338007E57Q29048610-6F8A045D-1BC5-4F3B-9A19-FDB3F6809995Q30398970-32882C54-0628-46A7-AF99-DECF3BA52D83Q33577258-621A758D-470E-4B35-9A2B-D94FAAA8C06EQ33658456-0479DFB6-0133-423A-8589-5B6AB5347CFFQ34432217-C2678005-6658-46E3-90C7-06F27F86F69AQ36053929-15A4B52D-35DD-468A-8B74-5A47E74EAE8FQ36705598-CF608494-4B91-4F1A-85A5-9AC479424DFCQ37196021-7C015849-B55B-482E-B2A4-9DD683412C63Q37277346-185A4B5E-122E-492D-9023-2CE2DCA5C625Q38811356-1DE1125F-13B4-4E83-A1E0-B8D52A681E0BQ38826634-44C4C794-BB13-4BDB-B9F5-0E9571C43297Q38932342-E838F239-6BDB-4D0C-81E5-36CBBAAB60DFQ42021947-60F20A9C-EB94-4F7D-8903-46A3C681AA8AQ42961772-DF88950E-A981-4F52-90D7-43B74A0B0105Q46478654-C9AB93F0-5697-4651-9332-5D12A7230922Q47524535-292AA8CC-59DA-414C-BE98-5BCF6DAD8404Q49912722-04E27FD7-3627-4F28-BB53-5A4B41658AC0Q50792998-065C682B-6142-496B-B27B-22B58451B0EEQ51296585-CB4BEEF3-3C0F-44A8-916E-C5944B0B78C0Q51359224-001CF394-8748-4584-9369-EF1CC6049925Q53179527-F5A2DECA-A0CE-4439-AB22-BA9B8053A367Q54958024-56CC5CD0-9893-4DE2-9EA1-3CEDA7D466F4Q55046775-F86D9AC8-7008-41AB-9268-A36E14302B27Q58761750-98530A99-F7D0-4E7B-887B-7BD3F00BFB97Q59291741-D6BAC2D4-243C-4AA3-907C-8DA7528284C1
P2860
Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pirfenidone inhibits fibrocyte ...... ced murine pulmonary fibrosis.
@en
Pirfenidone inhibits fibrocyte ...... ced murine pulmonary fibrosis.
@nl
type
label
Pirfenidone inhibits fibrocyte ...... ced murine pulmonary fibrosis.
@en
Pirfenidone inhibits fibrocyte ...... ced murine pulmonary fibrosis.
@nl
prefLabel
Pirfenidone inhibits fibrocyte ...... ced murine pulmonary fibrosis.
@en
Pirfenidone inhibits fibrocyte ...... ced murine pulmonary fibrosis.
@nl
P2093
P2860
P356
P1433
P1476
Pirfenidone inhibits fibrocyte ...... ced murine pulmonary fibrosis.
@en
P2093
Akihiko Gemma
Hiroki Hayashi
Kazue Fujita
Koichiro Kamio
Kuniko Matsuda
Minoru Inomata
Nariaki Kokuho
Takahito Nei
Yoshinobu Saito
Yukiko Miura
P2860
P2888
P356
10.1186/1465-9921-15-16
P50
P577
2014-02-08T00:00:00Z
P5875
P6179
1031889222